* BioHiTech Global Inc BHTG.OQ BHTG.O is expected to show a
rise in quarterly revenue when it reports results on May 17 .
* The Chestnut Ridge, New York-based company is expected to
report a 33.1% increase in revenue to $1.809 million from
$1.36 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for BioHiTech Global Inc is
for a loss of 8 cents per share. For the same quarter last year,
the company reported a loss of 16 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 11.1% in the last three months.
* Wall Street's median 12-month price target for BioHiTech
Global Inc is $5.25, about 77.3% above its last closing price
of $1.19.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 -0.08 -0.08 -0.14 Missed -75
Sep. 30 2020 -0.13 -0.13 -0.12 Beat 7.7
Jun. 30 2020 -0.11 -0.11 -0.16 Missed -45.5
Mar. 31 2020 -0.13 -0.13 -0.16 Missed -23.1
Dec. -0.15 -0.15 -0.15 Met 0
31 2019
Sep. 30 2019 -0.06 -0.06 -0.16 Missed -166.7
Jun. 30 2019 -0.05 -0.05 -0.15 Missed -200
Mar. 31 2019 -0.07 -0.07 -0.14 Missed -100
This summary was machine generated May 14 at 21:33 GMT. All
figures in US dollars unless otherwise stated